Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (351-360 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|June 12, 2019
Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune diseaseRobert J Benschop, Chi-Kin Chow, Yu Tian, et al.
Mabs|August 4, 2021
Host cell protein detection gap risk mitigation: quantitative IAC-MS for ELISA antibody reagent coverage determinationDaniel M Waldera-Lupa, Yvonne Jasper, Pia Köhne, et al.
Mabs|March 7, 2023
Blueprint for antibody biologics developabilityCarl Mieczkowski, Xuejin Zhang, Dana Lee, et al.
Mabs|February 17, 2023
Characterization of high-molecular weight by-products in the production of a trivalent bispecific 2+1 heterodimeric antibodyDario A T Cramer, Vojtech Franc, Anna-Katharina Heidenreich, et al.
Mabs|February 2, 2023
The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapyChristina Claus, Claudia Ferrara-Koller, Christian Klein
Mabs|February 2, 2023
Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potencyBaoshan Zhang, Jason Gorman, Young D Kwon, et al.
Mabs|January 27, 2023
Predictive modeling of concentration-dependent viscosity behavior of monoclonal antibody solutions using artificial neural networksJonathan Schmitt, Abbas Razvi, Christoph Grapentin
Mabs|February 21, 2023
SpyDisplay: A versatile phage display selection system using SpyTag/SpyCatcher technologySarah-Jane Kellmann, Christian Hentrich, Mateusz Putyrski, et al.
Mabs|February 13, 2026
Balancing the extremes for antibody developability: hydrophobic and electrostatic germline framework signatures for CDR-loop compensationVera A Spanke, Valentin J Egger-Hoerschinger, Clarissa A Seidler, et al.
Mabs|March 3, 2025
Optimizing asymmetric antibody purification: a semi-automated process and its digital integrationChristophe Prince, Despoina Georgiadou, Manuela Machatti, et al.
Pageof 184

Showing results (351-360 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|June 12, 2019
Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune diseaseRobert J Benschop, Chi-Kin Chow, Yu Tian, et al.
Mabs|August 4, 2021
Host cell protein detection gap risk mitigation: quantitative IAC-MS for ELISA antibody reagent coverage determinationDaniel M Waldera-Lupa, Yvonne Jasper, Pia Köhne, et al.
Mabs|March 7, 2023
Blueprint for antibody biologics developabilityCarl Mieczkowski, Xuejin Zhang, Dana Lee, et al.
Mabs|February 17, 2023
Characterization of high-molecular weight by-products in the production of a trivalent bispecific 2+1 heterodimeric antibodyDario A T Cramer, Vojtech Franc, Anna-Katharina Heidenreich, et al.
Mabs|February 2, 2023
The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapyChristina Claus, Claudia Ferrara-Koller, Christian Klein
Mabs|February 2, 2023
Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potencyBaoshan Zhang, Jason Gorman, Young D Kwon, et al.
Mabs|January 27, 2023
Predictive modeling of concentration-dependent viscosity behavior of monoclonal antibody solutions using artificial neural networksJonathan Schmitt, Abbas Razvi, Christoph Grapentin
Mabs|February 21, 2023
SpyDisplay: A versatile phage display selection system using SpyTag/SpyCatcher technologySarah-Jane Kellmann, Christian Hentrich, Mateusz Putyrski, et al.
Mabs|February 13, 2026
Balancing the extremes for antibody developability: hydrophobic and electrostatic germline framework signatures for CDR-loop compensationVera A Spanke, Valentin J Egger-Hoerschinger, Clarissa A Seidler, et al.
Mabs|March 3, 2025
Optimizing asymmetric antibody purification: a semi-automated process and its digital integrationChristophe Prince, Despoina Georgiadou, Manuela Machatti, et al.
Pageof 184